Spectrum Asset Management (California)’s Novo Nordisk NVO Stock Holding History

Spectrum Asset Management (California)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-48,400	Closed	-$1.3M	–	52
2016 Q2	$1.3M	Sell	48,400 -100	-0.2%	-$2.74K	1.54%	15
2016 Q1	$1.31M	Sell	48,500 -1,200	-2%	-$32.1K	1.65%	13
2015 Q4	$1.44M	Buy	49,700 +2,240	+5%	+$62K	1.64%	12
2015 Q3	$1.29M	Buy	47,460 +2,000	+4%	+$56.6K	1.51%	14
2015 Q2	$1.25M	Hold	45,460	–	–	1.07%	23
2015 Q1	$1.21M	Buy	+45,460	New	+$1.05M	1.07%	19

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Spectrum Asset Management (California)'s NVO Position: Q3 2016 in Review

Spectrum Asset Management (California) sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 48,400 shares — an estimated $1.3M sold.

Spectrum Asset Management (California) first reported a position in NVO in Q1 2015 and held it in 6 quarters. The position peaked at $1.44M in Q4 2015. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Spectrum Asset Management (California) reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
Spectrum Asset Management (California) sold 48,400 Novo Nordisk shares in Q3 2016, an estimated $1.3M.
Spectrum Asset Management (California) first reported a position in Novo Nordisk in Q1 2015 and held it in 6 quarters.
Spectrum Asset Management (California)'s Novo Nordisk position peaked at $1.44M in Q4 2015.
511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Spectrum Asset Management (California)'s 13F filing for Q3 2016, filed 25 Oct 2016.